tirzepatide semaglutide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are liraglutide to semaglutide conversion Mounjaro

Emerging model in anesthetic developmental neurotoxicity: human stem cells

Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases

While many different things can increase your risk for gout, what you eat has actually been found to be one of the top contributing factors

Step 5: Achieve and Maintain Your Goals Once you reach your target weight, your provider will help you transition to a maintenance plan